Vibrant Gastro

Executive Summary

Vibrant Gastro is an Israeli med-tech company commercializing the Vibrant® capsule, the first FDA-cleared drug-free vibrating capsule for chronic idiopathic constipation (CIC). The capsule uses Synchronized Activation Method™ to deliver micro-vibrations that restore natural colonic motility, offering a non-pharmacologic alternative for adults who have failed standard laxative therapy. This innovative approach addresses a significant unmet need, as many CIC patients are dissatisfied with laxatives due to side effects or inadequate efficacy. The FDA clearance positions Vibrant as a pioneering device in the gastrointestinal motility space, with a clear value proposition for both patients and healthcare providers seeking non-drug options. The company is currently focused on scaling commercialization through specialty pharmacy partnerships and federal contracts, including potential distribution through the Veterans Health Administration. With a growing prevalence of constipation and increasing demand for drug-free treatments, Vibrant is well-positioned to capture market share. The company's commercial-stage status indicates existing revenue, though specific financials are undisclosed. Looking ahead, expansion into additional indications (e.g., IBS-C) and broadening payer coverage represent key growth levers. As awareness and physician adoption increase, Vibrant could become a leading non-pharmacologic therapy for constipation, though competition from other neuromodulation and biofeedback devices remains a factor.

Upcoming Catalysts (preview)

• Q3 2026U.S. Federal Contract Expansion (e.g., Veterans Health Administration)60% success
• Q4 2026Partnership with Major Pharmacy Benefit Manager or National Retail Chain50% success
• Q2 2026Publication of Real-World Evidence Study Supporting Clinical Efficacy70% success